3 -5 FEBRUARY 2011JW MARRIOTT WASHINGTON,DC

BC3CONFERENCE.COM

CO-CHAIRS: SCOTT L. SPEAR, MD ■ SHAWNA C. WILLEY, MD

P r e l i m i n a r y P r o g r a m

Georgetown University HospitalA N I N T E R D I S C I P L I N A R Y C O N F E R E N C E

BC3Breast CancerCoordinated Care

Local Treatment • PreveEnhance Your Clin

■ Oncoplastic Surgery■ Partial Breast Irradiation■ Nipple-Sparing Mastectomy■ Intraoperative Radiation■ Prophylactic Mastectomy■ Locally Advanced Breast

Cancer■ Chemoprevention

■ Cancer in the Augmented Breast■ The High Risk Patient■ Alloplastic Materials■ Post Mastectomy Radiation■ MRI Screening for

Breast Cancer■ Radiation & Reconstruction

(R&R)

Topics to Improve the Coordination and Delivery of Care

■ Stay in deluxe accommodations at JW Marriott Washington, DC at the $249 conference rate

■ Just blocks from the White House, Washington Monument,Smithsonian Museums and the National Mall

■ Experience DC’s dynamic Downtown dining & shopping

■ Stay minutes from Reagan National Airport (DCA) and one block from the Metro, with plentiful parking options

■ Save on expenses! Conference reception/dinner, breakfasts and lunches are included

ntion • Reconstructionical Performance!

Call for Poster AbstractsDeadline: December 6, 2010 1 8 C M E s

Scott L. Spear, MDProfessor and ChairmanDepartment of Plastic

and Reconstructive Surgery

Shawna C. Willey, MDAssociate Professorof Clinical Surgery

Chief, Division of Breast Surgery

C O N F E R E N C E C O - C H A I R S

Douglas W. Arthur, MDVCU Medical Center / Massey Cancer Center

Richmond, VA

Andrew Ashikari, MDNew York Medical College

Dobbs Ferry, NY

Elisabeth K. Beahm, MDUniversity of Texas M. D. Anderson Cancer Center

Houston, TX

Peter D. Beitsch, MDDallas Breast Center

Dallas, TX

Klaus Brunnert, MDKlinik für Senologie und Plastische Chirurgie

Osnabrück, Germany

Grant W. Carlson, MDThe Emory Clinic

Atlanta, GA

Costanza Cocilovo, MDGeorgetown University Hospital

Washington, DC

Peter G. Cordeiro, MDMemorial Sloan-Kettering Cancer Center

New York, NY

Joseph P. Crowe Jr., MDCleveland ClinicCleveland, OH

Prof. J. Michael DixonWestern General Hospital

Edinburgh, Scotland

Elizabeth D. Feldman, MDGeorgetown University Hospital

Washington, DC

Armando E. Giuliano, MDJohn Wayne Cancer Institute

Santa Monica, CA

Kelly K. Hunt, MDUniversity of Texas M. D. Anderson Cancer Center

Houston, TX

Claudine Isaacs, MDGeorgetown University Hospital

Washington, DC

Stephen J. Kronowitz, MDUniversity of Texas M. D. Anderson Cancer Center

Houston, TX

Robert R. Kuske Jr., MDArizona Breast Cancer Specialists

Scottsdale, AZ

Albert Losken, MDThe Emory Clinic

Atlanta, GA

G. Patrick Maxwell, MDMaxwell Aesthetics

Nashville, TN

Maurice Y. Nahabedian, MDGeorgetown University Hospital

Washington, DC

Maurizio B. Nava, MDInstituto Nazionale dei Tumori

Milano, Italy

F A C U L T Y

Georgetown University Hospital ■ Washington, DC

B C 3 P R O G R A M C O M M I T T E E

Abram Recht, MDBeth Israel Deaconess Medical Center

Boston, MA

Gino Rigotti, MDAzienda Ospedaliera Universitaria di Verona

Verona, Italy

Geoffrey L. Robb, MDUniversity of Texas M. D. Anderson Cancer Center

Houston, TX

Jennifer Rusby, MDRoyal Marsden Hospital

Sutton, UK

Virgilio Sacchini, MDMemorial Sloan-Kettering Cancer Center

New York, NY

C. Andrew Salzberg, MDNew York Group for Plastic Surgery

Tarrytown, NY

Joseph M. Serletti, MDUniversity of Pennsylvania Health System

Philadelphia, PA

Sumner A. Slavin, MDHarvard Medical School

Boston, MA

Eric A. Strom, MDUniversity of Texas M. D. Anderson Cancer Center

Houston, TX

Frank A. Vicini, MDWilliam Beaumont Hospital

Royal Oak, MI

Dale Collins Vidal, MDDartmouth-Hitchcock Medical Center

Lebanon, NH

Pat W. Whitworth, MDNashville Breast Center

Nashville, TN

Douglas W. Arthur, MD

Peter D. Beitsch, MD

Grant W. Carlson, MD

Costanza Cocilovo, MD

Peter G. Cordeiro, MD

Elizabeth D. Feldman, MD

Robert R. Kuske Jr., MD

G. Patrick Maxwell, MD

Maurice Y. Nahabedian, MD

Maurizio B. Nava, MD

Geoffrey L. Robb, MD

Joseph M. Serletti, MD

Sumner A. Slavin, MD

Dale Collins Vidal, MD

Thursday 3 February 2011

11:00 - 12:00 Lunch Symposium - TBA

BREAST CANCER COORDINATED CARE

12:00 -12:10 Opening RemarksLouis M. Weiner, MDDirector, Georgetown Lombardi Comprehensive Cancer Center

12:10 -12:30 IntroductionScott L. Spear, MD; Shawna C. Willey, MD

BC3: MODELS OF COORDINATED CARE: (Center Specific Systems, Philosophy and Evidence)

12:30 - 12:45 Georgetown University HospitalShawna C. Willey, MD

12:45 - 1:00 Nashville Breast CenterPat W. Whitworth, MD

1:00 - 1:15 John Wayne Cancer InstituteArmando E. Giuliano, MD

1:15 - 1:30 M. D. Anderson Cancer CenterKelly K. Hunt, MD

1:30 - 2:00 Panel Discussion / Q & AModerator: Peter D. Beitsch, MD

APPROACHES TO ONCOPLASTIC SURGERY

2:00 - 2:10 A European Plastic Surgeon’s Perspective on Oncoplastic Surgery Maurizio B. Nava, MD

2:10 - 2:20 An American Plastic Surgeon’s Perspective on Oncoplastic SurgeryAlbert Losken, MD

2:20 - 2:30 A European Breast Surgeon’s Perspective on Oncoplastic SurgeryProf. J. Michael Dixon

2:30 - 2:40 An American Breast Surgeon’s Perspective on Oncoplastic SurgeryPat W. Whitworth, MD

2:40 - 2:50 A Radiation Oncologist’s Perspective on Oncoplastic SurgeryRobert R. Kuske Jr., MD

2:50 - 3:30 Panel Discussion / Q & A / ARSModerator: Sumner A. Slavin, MD

3:30 - 4:00 Break

UPDATE ON RADIATION WITH BREAST CONSERVATION

4:00 - 4:20 Accelerated Partial Breast Irradiation: Are All APBI Techniques Created Equal?(Including Cyberknife, Brachytherapy, IORT) Frank A. Vicini, MD

4:20 - 4:40 Whole Breast Radiation: Controversies in Treatment Protocols and Their Impact on Coordinating Surgical Care(Including Intensity Modulated Radiation Therapy & Prone Radiation)Abram Recht, MD

DOES RECONSTRUCTION IMPACT POST-MASTECTOMY RADIATION?

4:40 - 4:50 The M. D. Anderson PerspectiveEric A. Strom, MD

4:50 - 5:00 The Harvard PerspectiveAbram Recht, MD

5:00 - 5:30 Panel Discussion / Q & A / ARSModerator: Douglas W. Arthur, MD

5:30 - 7:00 Reception / Dinner with Exhibitors

Friday 4 February 2011

7:00 - 8:00 Breakfast Symposium - TBA

7:00 - 8:00 Breakfast

PROPHYLACTIC MASTECTOMY

8:00 - 8:15 Is Nipple-Sparing Prophylactic Mastectomy Safe?Jennifer Rusby, MD

8:15 - 8:30 The Case Against Nipple-Sparing Prophylactic MastectomyKelly K. Hunt, MD

NIPPLE-SPARING PROPHYLACTIC MASTECTOMY - WHERE DO I CUT?

8:30 - 8:45 Inframammary Andrew Ashikari, MD

8:45 - 9:00 Lateral Joseph P. Crowe Jr., MD

9:00 - 9:15 Pros & Cons: Sentinel Node Excision with Prophylactic MastectomyArmando E. Giuliano, MD

9:15 - 9:30 Nipple-Sparing in Non-Ideal PatientsScott L. Spear, MD

9:30 - 9:45 Avoiding Flap Necrosis and Other Technical Surgical StrategiesPat W. Whitworth, MD

9:45 - 10:15 Panel Discussion / Q & A / ARSModerator: Prof. J. Michael Dixon

10:15 - 11:00 Break / Exhibits

11:00 - 11:15 One-Stage Reconstruction - Direct to ImplantC. Andrew Salzberg, MD

11:15 - 11:30 Two-Stage Reconstruction - Expander to ImplantG. Patrick Maxwell, MD

11:30 - 11:45 Autologous Reconstruction after Prophylactic MastectomyJoseph M. Serletti, MD

11:45 - 12:15 Panel Discussion / Q & A / ARSModerator: Grant W. Carlson, MD

12:15 - 1:45 Lunch / Exhibits

12:30 - 1:30 Lunch Symposium - TBA

CONTROVERSIES IN LOCAL CONTROL

1:45 - 1:55 Post-Mastectomy Radiation - When Is It Really Needed?Eric A. Strom, MD

IS THERE A ROLE FOR THERAPEUTIC NIPPLE-SPARING MASTECTOMY?

1:55 - 2:05 Memorial Sloan-Kettering PerspectiveVergilio Sacchini, MD

2:05 - 2:15 The Cleveland Clinic ExperienceJoseph P. Crowe Jr., MD

2:15 - 2:25 The Emory PerspectiveGrant W. Carlson, MD

2:25 - 2:40 The Role of Breast Conservation in the Cancer Treatment of the BRCA Positive PatientJennifer Rusby, MD

2:40 - 2:55 The Role of Mastectomy in the Cancer Treatment of the BRCA Positive PatientJoseph P. Crowe Jr., MD

2:55 - 3:10 Cancer Treatment in the Previously-Augmented PatientA Surgeon’s PerspectiveKelly K. Hunt, MD

3:10 - 3:40 Panel Discussion / Q & A / ARSModerator: Armando E. Giuliano, MD

3:40 - 4:25 Break / Exhibits

4:25 - 4:40 Management of an Incidental Breast Cancer Foundat the Time of Breast ReductionElizabeth D. Feldman, MD

4:40 - 4:55 Strategies for Ensuring Clean Margins with Intraoperative Radiation TherapyPeter D. Beitsch, MD

4:55 - 5:10 Coordinating Oncoplastic Surgery with Partial Breast RadiationGeoffrey L. Robb, MD

5:10 - 5:25 Intraoperative Radiation Therapy Combined with Nipple-Sparing Mastectomy: Is it Necessary and Safe?Maurizio B. Nava, MD

5:25 - 6:00 Panel Discussion / Q & A / ARSModerator: Dale Collins Vidal, MD

Saturday 5 February 2011

7:00 - 8:00 Breakfast Symposium - TBA

7:00 - 8:30 Breakfast

BREAST RECONSTRUCTION

TIMING OF AUTOLOGOUS RECONSTRUCTION IN THE PATIENT RECEIVING POST-MASTECTOMY RADIATION

8:15 - 8:25 Immediate Joseph M. Serletti, MD

8:25 - 8:35 Delayed Maurice Y. Nahabedian, MD

8:35 - 8:45 Harvard PerspectiveSumner A. Slavin, MD

STRATEGIES IN PROSTHETIC RECONSTRUCTION IN THE PATIENT RECEIVING POST-MASTECTOMY RADIATION

8:45 - 8:55 Dartmouth-Hitchcock Medical CenterDale Collins Vidal, MD

8:55 - 9:05 M. D. Anderson Cancer CenterStephen J. Kronowitz, MD

9:05 - 9:15 Memorial Sloan-KetteringPeter G. Cordeiro, MD

9:15 - 9:25 Georgetown University HospitalScott L. Spear, MD

9:25 - 10:00 Panel Discussion / Q & A / ARSModerator: Geoffrey L. Robb, MD

10:00 - 10:45 Break / Exhibits

10:45 - 11:00 Role of Alloplastic Materials in Implant-Based Breast ReconstructionC. Andrew Salzberg, MD

11:00 - 11:15 Role of Alloplastic Materials in the Reconstructionof the Radiated Breast Maurice Y. Nahabedian, MD

11:15 - 11:30 The Role of Fat in Breast Reconstruction as an Adjunct to Flaps and Implants - Pros & Cons Elisabeth K. Beahm, MD

11:30 - 11:45 Immediate and Late Reconstruction of the Lumpectomy Defect with Flaps Sumner A. Slavin, MD

11:45 - 12:00 Autologous Fat and Stem Cells for Lumpectomy DefectsGino Rigotti, MD

12:00 - 12:30 Panel Discussion / Q & A / ARSModerator: G. Patrick Maxwell, MD

12:30 - 1:45 Lunch / Exhibits

12:40 - 1:40 Lunch Symposium - TBA

CONTROVERSIES WITH ADVANCED DISEASEBroad Strokes: Sequencing of Therapy for Locally Advanced Disease

NEOADJUVANT THERAPY AND ITS IMPLICATIONS ON STAGING AND LOCAL THERAPY

1:45 - 2:00 Preoperative Endocrine TherapyProf. J. Michael Dixon

2:00 - 2:15 Preoperative ChemotherapyClaudine Isaacs, MD

2:15 - 2:30 Managing Locally Recurrent Breast Cancer Post MastectomyCostanza Cocilovo, MD

2:30 - 2:45 Is There a Role for Breast “Reconservation”?Klaus Brunnert, MD

2:45 - 3:00 Radiation in the Previously Radiated PatientDouglas W. Arthur, MD

LOCAL CONTROL IN PATIENTS WITH METASTATIC DISEASE

3:00 - 3:15 Radiation OncologistRobert R. Kuske Jr., MD

3:15 - 3:30 Surgical OncologistShawna C. Willey, MD

3:30 - 4:00 Panel Discussion / Q & A / ARSModerator: Klaus Brunnert, MD

4:00 - 4:15 Closing RemarksScott L. Spear, MD; Shawna C. Willey, MD

Accreditation Statement: The Georgetown University Hospital is accredited by the Accreditation Council for ContinuingMedical Education to provide continuing medical education for physicians.

The Georgetown University Hospital designates this educational activity for a maximum of 18 AMA PRA Category 1 Credit(s)™.Physicians should only claim credit commensurate with the extent of their participation in the activity.

Georgetown University Hospital Department of Nursing Education is an approved provider of continuing nursing education by theMaryland Nurses Association, an accredited provider by the American Nurses Credentialing Center’s Commission on accreditation. Nurseswill be awarded a maximum of 18 contact hours for successfully completing the program.

Disclosure of Financial Relationships with Any Commercial InterestAs a sponsor accredited by the ACCME, it is the policy of Georgetown University Hospital to require that everyone who is in the position tocontrol the content of an educational activity disclose all relevant financial relationships with any commercial interest prior to theeducational activity. The ACCME considers relationship of the person involved in the CME activity to include financial relationship of aspouse or partner. Faculty and planners who refuse to disclose relevant financial relationships will be disqualified from participating in theCME activity. For an individual with no relevant financial relationship(s), the participant must be informed that no conflicts of interest or financialrelationship(s) exist.

Conference Objectives: Following this program, participants should have a thorough understanding of the important controversialaspects of coordinated local treatment of breast cancer and breast reconstruction. They will be aware of the pros and cons regardingprophylactic mastectomy, as well as the pros and cons regarding nipple-sparing in both prophylactic and therapeutic mastectomy. They willunderstand surgical techniques designed to improve the likelihood of nipple preservation and reduce the risk of flap or nipple necrosis withmastectomy. They will have a more complete understanding of the impact of reconstruction on post-mastectomy radiation delivery and,conversely, of the impact of post-mastectomy radiation on prior reconstruction. They will learn different philosophies regarding radiationdelivery including new techniques and how to minimize side effects to the surrounding tissue. They will obtain a better understanding ofthe arguments regarding re-staging patients after neoadjuvant chemotherapy and the pros and cons of downstaging based upon response tochemotherapy pre-mastectomy on the subsequent treatment plan, the scope and power of oncoplastic surgery in the patient who undergoesbreast conservation therapy for breast cancer, and the arguments in favor of a coordinated team approach in oncoplastic surgery tomaximize the cosmetic and oncologic outcomes. Attendees will also become familiar with different methods of breast reconstructionincluding implant-based reconstruction, flap-based reconstruction, and microsurgical-assisted free flap reconstruction. They will becomeaware of the proper patient selection and timing for these procedures as well as the evolving role of alloplastic materials in breastreconstruction both in terms of enhancing and facilitating device reconstruction of the breast, as well as reconstructing the abdomen afterflap harvesting.

Target Audience: This program is specifically designed to be a multidisciplinary program and is intended for a wide range of medicalpractitioners who are interested in the latest information regarding the local treatment of breast cancer. The program is purposely targeted forgeneral, plastic, breast and oncologic surgeons, as well as radiation & medical oncologists. It is also intended for primary care physicians, oncologynurses and practitioners, genetic counselors and hospital administrators who have an interest in the treatment of breast cancer patients.

Course Description: Breast cancer is the most common cancer affecting women. Its diagnosis and treatment are part of the practice ofa wide number of medical specialties including primary care physicians, medical oncologists, surgical oncologists, breast surgeons, plasticsurgeons, radiation oncologists, psychologists and other healthcare professions. There are national initiatives calling for a multidisciplinaryapproach to the care of these patients.The multiple components and aspects of the treatment of breast cancer require a high level of coordinatedcare among different specialties. This coordination becomes even more challenging because of the rapid evolution of new treatment modalitiesand is especially important because of the possibility of improved outcomes both in terms of curing the disease, as well as maintaining the physicaland psychological well-being of the patient. This meeting is the first of its kind to assemble an international faculty of specialists focused on thelocal treatment of breast cancer including breast surgeons, plastic surgeons and radiation oncologists. The intent of the meeting is to present arange of treatment options and points of view from different specialties regarding specific controversial areas of treatment.

The meeting will offer presentations and panel discussions on a number of currently important topics in the local treatment of breast cancerincluding oncoplastic surgery, the role of prophylactic mastectomy, the state of partial breast irradiation, intraoperative radiation therapy, timingand indications for post-mastectomy radiation, neoadjuvant chemotherapy and its role in restaging breast cancer, nipple-sparing mastectomyboth therapeutic and prophylactic, treatment of breast cancer in a previously augmented breast, the status of MRI screening for breast cancer,the effects of reconstruction on the delivery of post-mastectomy radiation, and the evolving role of alloplastic materials in breast reconstruction.

Attendees will hear different models for coordination of breast cancer from major centers across the USA. They will also hear arguments forand against treatments such as nipple-sparing mastectomy in the patient with breast cancer and the timing of reconstruction vis-a-vis post-mastectomy radiation therapy. The meeting’s intent is not only to educate the faculty and attendees about the wide range of options availablefor breast cancer coordinated care, but also to encourage the development of more standardized treatment strategies and protocols in the localtreatment of breast cancer.

Acknowledgment: This continuing medical education activity is supported by unrestricted educational grants and exhibitor & commercialsupport from contributing organizations, each of which will be identified in course materials at the conference.

Advisory: Certificates of Attendance for CMEs and Contact Hours will be available for you to print online during and after this conference.

TARGET AUDIENCE:General, Plastic, Breast and Oncologic Surgeons

Radiation and Medical Oncologists ✦ Primary Care PhysiciansOncology Nurses & Practitioners ✦ Genetic Counselors ✦ Hospital Administrators

BC3 Conference Headquarters ▲ 1018 Harding Street, Suite 207 ▲ Lafayette, LA 70503 Tel: 337.235.6606 ▲ Fax: 337.235.7300 ▲ info@BC3conference.com

Presenting Sponsor: Managed by:CONFERENCE MANAGEMENT

BC3 Conference VenueJW Marriott Washington, DC

1331 Pennsylvania Avenue ▲ Washington, DC 20004 USA

Enjoy a world-famous location and world-class facilities at the JW Marriott Washington, DC.This prestigious hotel is near Washington’s most recognizable landmarks, including the WhiteHouse, the National Theatre, and the National Portrait Gallery. Within walking distance of the

Smithsonian museums and the Washington Monument, and close to shopping andrestaurants, our headquarters hotel is one block from Washington’s Metro system and just15 minutes from Reagan National Airport. Valet parking (fee) is available at the hotel. For

additional parking options, please see the conference website at www.BC3conference.com.Mention “Breast Cancer Coordinated Care” or “BC3” to receive the group rate

of $249 by calling 800-266-9432 ▲ 506-474-2009or visit www.BC3conference.com

YOU WILL RECEIVE AN EMAIL CONFIRMATION OF YOUR REGISTRATIONMAIL TO: BC3 ADMINISTRATIVE HEADQUARTERS • 1018 HARDING STREET • SUITE 207 • LAFAYETTE, LA 70503

FAX: 337.235.7300 • TEL: 337.235.6606 • registration@BC3conference.com • www.BC3conference.com

GUEST FEESCompanion � $100 Includes Welcome Reception and Dinner with Open Bar, All Conference Meals,

and Access to ExhibitsReception � $50 Includes Welcome Reception and Dinner with Open Bar

Guest Name_______________________________________________________________

BC3Breast CancerCoordinated Care

REGISTRATION FEES Before BEFORE BEFORE BEFORE BEFORE FEB. 2May 17 July 26 SEPT. 13 NOV. 22 FEB. 2 THRU ONSITE

MDs/DOs � $600 � $650 � $700 � $800 � $850 � $900RNs/Allied Health Professionals � $350 � $400 � $450 � $500 � $550 � $600Residents/Students* � $200 (*Proof Required)

Industry � $900MDs/DOs – One Day � $375 Check One: � Thur. � Fri. � Sat.RNs/Allied Health Professionals–One Day � $325 Check One: � Thur. � Fri. � Sat.

CANCELLATION POLICY If your registration must be cancelled, the course fee less $150 administrative costs will be refunded if we are notified in writing by December 17, 2010. After December 17, 2010, no refunds will be given.

NAME (as it is to appear on your name badge) TITLE/DEGREE

POSITION (if applicable) SPECIALTY (required)

AFFILIATION / INSTITUTION

STREET ADDRESS

CITY STATE/PROV

PHONE EXTENSION FAX

EMAIL (required for confirmation)

ZIP CODE

CONFERENCE HOTEL • JW MARRIOTT WASHINGTON, DC1331 Pennsylvania Avenue NW • Washington, DC 20004 • Reservations 800-266-9432 • 506-474-2009

BC3 Conference Rate $249 • Mention “Breast Cancer Coordinated Care” or “BC3” to secure discounted conference rate

JW MARRIOTT WASHINGTON, DC

REGISTRATION ◆ Tuition ◆ Online Course Webcast ◆ CMEs/Contact Hours ◆ Five Breaks INCLUDES ◆ Welcome Reception & Dinner with Open Bar ◆ Two Breakfasts & Lunches

◆ Breakfast & Lunch Symposia

COUNTRY

CONFERENCE REGISTRATION 3 – 5 FEBRUARY 2011

Register online at www.BC3conference.com or Fax to: 337-235-7300

PAYMENT METHOD

� Enclosed is a check in the amount of $_______________

(Please make checks payable to Georgetown University Hospital)� Charge my credit card the amount of $ __________

� Visa � MasterCard � American Express � Discover

Card#___________________________________________________________________________________

Exp. Date _____/______ Security Code #_________

Cardholder ’s Name (please print)____________________________________________________________

Signature________________________________________________________________________________

Geo

rget

own

Uni

vers

ity

Hos

pita

l38

00 R

eser

voir

Rd.

NW

Was

hing

ton,

DC

20

007

NO

N P

RO

FIT

OR

G.

U.S

. P

osta

ge

PAID

Nas

hvill

e, T

NP

erm

it N

O.

4398

ww

w.B

C3

co

nfe

ren

ce

.co

m

CA

LL F

OR

PO

STE

R A

BS

TRA

CTS

18

CM

Es

3TH

UR

SD

AY —5

SA

TUR

DAY

Feb

ruar

y 20

11J

W M

arr

iott

WA

SH

IN

GT

ON

,DC

Geo

rg

et

ow

n U

niv

er

sit

y H

osp

ita

l

BC

3B

rea

st C

an

cer

Co

or

din

at

ed

Ca

re